Schechter Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $456K | Sell |
719
-136
| -16% | -$86.3K | 0.04% | 387 |
|
|
2024
Q4 | $609K | Sell |
855
-117
| -12% | -$83.3K | 0.05% | 343 |
|
|
2024
Q3 | $1.02M | Sell |
972
-4
| -0.4% | -$4.21K | 0.08% | 250 |
|
|
2024
Q2 | $1.03M | Buy |
976
+9
| +0.9% | +$9.46K | 0.08% | 231 |
|
|
2024
Q1 | $931K | Sell |
967
-2
| -0.2% | -$1.93K | 0.07% | 258 |
|
|
2023
Q4 | $851K | Sell |
969
-13
| -1% | -$11.4K | 0.07% | 258 |
|
|
2023
Q3 | $808K | Sell |
982
-25
| -2% | -$20.6K | 0.08% | 256 |
|
|
2023
Q2 | $724K | Sell |
1,007
-14
| -1% | -$10.1K | 0.07% | 310 |
|
|
2023
Q1 | $839K | Buy |
1,021
+64
| +7% | +$52.6K | 0.08% | 290 |
|
|
2022
Q4 | $690K | Sell |
957
-3
| -0.3% | -$2.16K | 0.06% | 404 |
|
|
2022
Q3 | $662K | Buy |
960
+97
| +11% | +$66.9K | 0.07% | 413 |
|
|
2022
Q2 | $510K | Buy |
863
+58
| +7% | +$34.3K | 0.05% | 517 |
|
|
2022
Q1 | $563K | Buy |
805
+73
| +10% | +$51.1K | 0.05% | 493 |
|
|
2021
Q4 | $463K | Buy |
+732
| New | +$463K | 0.04% | 532 |
|